Specific oncogene plays a role in lung squamous cell carcinoma

Jul 27, 2010

The identification of an oncogene (called BRF2) specific to lung squamous cell carcinoma suggests that genetic activation of this oncogene could be used as an identification marker for this type of lung cancer. Furthermore, this oncogene may provide a new target for therapeutics for lung squamous cell carcinoma. These findings come from a study by William Lockwood and colleagues from the BC Cancer Agency's Research Centre in Vancouver, Canada, and are reported in this week's PLoS Medicine.

Lung cancer is the most common cause of cancer-related death, killing 1.3 million people every year worldwide. Most cases of are "non-small cell lung cancers" of which there are 2 main types: squamous cell and adenocarcinoma.

The authors used a comparative genetic hybridisation technique to show that the focal amplification of chromosome region 8p12 plays a role in the development of lung (in about 40% of cases) but not in the development of lung adenocarcinoma where DNA loss in this chromosomal region is the most common alteration. The BRF2 was frequently activated in pre-invasive stages of lung squamous cell carcinoma — carcinoma in situ and dysplasia.

The authors conclude: "This is the first study, to our knowledge, to show that the focal amplification of a gene in chromosome 8p12 plays a key role in squamous cell lineage specificity of the disease. Our data suggest that genetic activation of BRF2 represents a unique mechanism of lung squamous cell carcinoma tumorgenesis." They add, "It [BRF2] can serve as a marker of lung squamous cell carcinoma and may provide a novel target for therapy."

Explore further: The fine line between breast cancer and normal tissues

More information: Lockwood WW, Chari R, et al. (2010) Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma. PLoS Med 7(7): e1000315. doi:10.1371/journal.pmed.1000315

add to favorites email to friend print save as pdf

Related Stories

New genetic techniques to combat lung cancer

Apr 25, 2008

New results on genetic techniques that are helping doctors diagnose and treat lung cancer were released today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) ...

HPV infection linked to increased risk of skin cancer

Jul 09, 2010

HPV infection heightens the risk of developing certain skin cancers and is worsened if people are taking immunosuppression drugs, according to a new study published in the British Medical Journal today.

Gene May Hold Key to Reducing Spread of Oral Cancers

Jul 23, 2010

(PhysOrg.com) -- The spread of cancer cells in the tongue may be reduced if a gene that regulates cancer cell migration can be controlled, according to new research at the University of Illinois at Chicago.

Recommended for you

The fine line between breast cancer and normal tissues

11 hours ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

12 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

15 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

17 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments : 0